Immunome, Inc.
Clinical trials sponsored by Immunome, Inc., explained in plain language.
-
First human test checks new Drug's heart safety
Knowledge-focused CompletedThis early-stage study aimed to see if a single dose of an experimental drug called varegacestat affects the heart's electrical rhythm. It involved 32 healthy adults who received the drug, a placebo, and a known heart-affecting drug for comparison. The main goal was to gather saf…
Phase: PHASE1 • Sponsor: Immunome, Inc. • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC
-
Scientists track a Drug's journey through the body
Knowledge-focused CompletedThis early-stage study aimed to understand how the body absorbs, breaks down, and eliminates the drug varegacestat. Six healthy adult men received a single oral dose containing a tiny, safe amount of radioactive tracer. Researchers collected blood, urine, and stool samples for ov…
Phase: PHASE1 • Sponsor: Immunome, Inc. • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:31 UTC
-
First step: testing a Drug's safety in people with liver issues
Knowledge-focused CompletedThis early-stage study aimed to understand how a single dose of an experimental drug, varegacestat, is processed by the body in people with different levels of liver impairment compared to healthy people. It involved 35 adults, some with liver problems and some without, to measur…
Phase: PHASE1 • Sponsor: Immunome, Inc. • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC